Where Ireland Builds the Next Chapter of Biopharma Excellence

Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and contract testing provider focused exclusively on cell and gene therapies. The company is headquartered in Philadelphia, Pennsylvania, and has more than 730,000 square feet of infrastructure across the United States, Europe, and Asia. Minaris Advanced Therapies has manufactured and released over 7,500 GMP batches on behalf of its clients and supports therapy developers from early-stage development and clinical trials to commercial manufacturing. By combining scientific expertise with best-in-class manufacturing and testing services, the company helps bring safe, effective therapies to patients faster and more efficiently. Visit minaris.com to learn more or download the new company presentation here.

Sartorius is a leading global partner of the biopharmaceutical industry dedicated to enabling cell and gene therapy developers to manufacture and commercialize their advanced therapy medicinal products (ATMPs). Over the last decade the company has expanded its legacy portfolio of single-use bioprocessing solutions through the acquisition of complementary advanced therapy consumables, services, and technologies—from plasmid engineering and manufacturing to cell culture media, reagents and monolithic chromatography. Sartorius’ advanced therapy solutions are designed to overcome current ATMP production challenges by enhancing productivity, improving process economics, and supporting safe and regulatory compliant manufacturing. Sartorius products are currently used in approved cell and gene therapies and actively support clinical pipelines worldwide. The company’s continued investment in innovative solutions demonstrates their commitment to advancing the field and making access to these life-saving treatments a reality.

Octapharma are the world's largest privately-owned plasma fractionator, with over 40 years of experience in the industry. Octapharma produce a range of GMP-grade plasma-derived proteins and serum media additives for the life sciences sector. Suitable for cell and gene therapy, vaccine development, RNA/ DNA therapeutics, in vitro diagnostics, immunoassays, and wider CDMO/ CRO/ CMO usage. All proteins are GMP grade, produced to a medicinal standard, and double-pathogen reduced. Bespoke and tailored regulatory documents can also be supplied to support approval body submission where material is listed as excipient. With several concentrations available for each product, we can confidently support small-scale laboratory use, right through to end-product manufacture, supporting all paces of company scale up.

BASF Pharma Solutions produces innovative excipients and active ingredients of outstanding quality and performance. With a global team of experienced industry specialists and digital solutions, such as the Virtual Pharma Assistants, BASF supports its customers in developing efficient, cost-effective and reliable formulations. Equipped with an in-depth understanding of multiple technologies and applications, BASF has the skills and resources to make drug manufacturing and drug delivery safer and more sustainable.

‍

Clean Cells is a GMP-certified, FDA-inspected CRO/CMO specializing in biosafety and quality control for biologics, cell and gene therapies, and advanced therapeutics. We support developers from preclinical research to commercial production, offering GMP-compliant biosafety testing, GMP cell and viral bank production, secure storage solutions, and the development of tailored analysis.

Our analytical expertise includes rapid microbiology (qPCR, BactALert), viral safety assays, identity testing (NGS, qPCR), and purity assessment (HCP, residual DNA, etc.). Visit our booth to discuss how we can help accelerate your regulatory success.

Merck is a leading science and technology company. Our BioReliance® biosafety testing and analytical development services deliver risk-mitigating solutions with technical and regulatory expertise. We partner with clients through the product cycle, from early pre-clinical development through licensed production, to help ensure the safety of the world’s therapeutics. SigmaAldrich.com/BiosafetyTesting

Pharma at Brenntag is more than you think. From specialty ingredients distribution to GMP manufacturing and services, Brenntag Pharma is the trusted advisor to the biopharmaceutical and pharmaceutical industry. With a dedicated team of industry experts, it creates value for their global business partners through customized buffer solutions and repackaging under GMP conditions, warehousing in GDP sites, regulatory support, analytical services and more. Brenntag Pharma serves various markets, including Biopharma, APIs, Excipients, Regulated Synthesis and Nutritional Health.